

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Tom Clements, 803-834-3084
Nick Berning, 202-222-0748
Friends of the Earth has learned that Duke Energy has taken a
decisive step which signals its complete withdrawal from the Department
of Energy's controversial program to test the potential use of surplus
military plutonium as fuel for commercial nuclear reactors.
In a stunning and silent move, Duke Energy has decided not to
reload experimental plutonium fuel (mixed oxide fuel, MOX) test
assemblies into its Catawba Unit 1 reactor during the current fuel
outage which began on November 6. This move is a major setback to the
Department of Energy's goal of using MOX fuel in commercial reactors.
Such an outage is a normal procedure, as the radioactive uranium fuel
must be withdrawn from the reactor core every 18 months.
This refueling outage began two weeks early due to a reactor
cooling pump leak which had to be repaired and which, according to the
Nuclear Regulatory Commission, was not a reportable event because the
radioactive water leakage was within technical specifications.
"Duke's total abandonment of the plutonium fuel program should be
a wake-up call to the Energy Department. Plans to force the use of this
costly and dangerous fuel in U.S. reactors must be immediately halted,"
said Tom Clements, Southeastern Nuclear Campaign Coordinator for
Friends of the Earth. "That it took Duke a full ten years to pull out
of the MOX program is a good indicator of more trouble ahead with
respect to costs, schedule and safety. It's not too late to pull the
plug on the entire misguided program, halt construction of an expensive
MOX plant under construction at the Savannah River Site and pursue a
cheaper, safer and faster alternative: management of plutonium as
nuclear waste."
Duke's decision to abandon the first-ever testing of MOX fuel made
from surplus weapons plutonium is a huge setback to the Department of
Energy, as the Nuclear Regulatory Commission will now not be able to
license full-scale MOX use. In order to be used with uranium fuel in a
nuclear reactor, the MOX fuel must perform acceptably during three
18-month test irradiation cycles. But the four MOX "lead test
assemblies" being tested at the Catawba reactor were withdrawn from the
reactor in May 2008 after only two cycles due to poor performance and
placed in the plant's spent fuel storage pool. Five rods were withdrawn
from one fuel assembly and shipped to Oak Ridge National Lab for
examination, but no test results have been made public.
Duke Energy, under contract with Shaw Areva MOX Services to
conduct the MOX test, has apparently now scrapped not only the MOX
reload but also halted reconsideration of any long-term MOX use in its
Catawba and McGuire reactors. Duke had signed a contract in 1999 "to
purchase mixed-oxide fuel for use in the McGuire and Catawba nuclear
reactors" and to conduct a test with the experimental fuel.
Use of MOX fuel has long drawn criticism from non-proliferation
and environmental groups due to the costs, safety concerns and
proliferation risks involved in processing, transporting and using such
fuel. In letters sent on November 10, 2009, Friends of the Earth
demanded assurances from the NRC that the aborted partial MOX test will
not be used as a justification for licensing MOX use and called on the
Department of Energy to halt construction of the $5 billion MOX factory
now underway at its Savannah River Site in South Carolina until such
time as full MOX use in nuclear reactors is licensed and MOX reactors
are contracted.
The test assemblies were manufactured in France in a now-closed
facility at Cadarache, leaving the Department of Energy with no
fabrication option for new tests of the experimental fuel. A repeat of
the MOX test would take approximately seven years, including NRC
licensing procedures, fuel fabrication, irradiation (three 18-month
cycles, taking a total of 54 months), and post-irradiation examination.
Now, with the loss of Duke, the Department of Energy has no
reactors lined up to use the MOX product from the MOX factory under
construction at its Savannah River Site. DOE claims that it is talking
to various nuclear utilities about MOX use, including the Tennessee
Valley Authority, but it is unknown if those utilities are aware that
they would have to conduct a lengthy test no matter the reactor type
they might propose for the program. Additionally, MOX alters reactor
performance and would result in more release of radiation in a severe
accident.
Acting in the public interest, Friends of the Earth and the Union
of Concerned Scientists revealed on August 4, 2008 that the MOX test
fuel had been prematurely withdrawn from the Catawba reactor. The
Department of Energy never issued a statement about that test failure
and Friends of the Earth now calls on the Department to issue a full
explanation of the failed test and Duke's abandonment of the program.
Resources:
November 10 letter to the Department of Energy:
https://www.foe.org/sites/default/files/Letter_Chu_on_MOX_test.pdf
November 10 letter to the Nuclear Regulatory Commission:
https://www.foe.org/sites/default/files/Letter_NRC_on_MOX_test.pdf
Notes:
1. Pertinent FOE news releases on MOX:
March 13, 2009: "DOE's Plans to Use Plutonium Fuel (MOX) Jolted by Duke Energy's Withdrawal," https://www.foe.org/plutonium-fuel-plan-hits-roadblock
August 8, 2009 "Nuclear Fuel Test Failure should Trigger Suspension of Weapons-Grade Plutonium Fuel Use," https://www.foe.org/nuclear-fuel-test-failure-raises-concerns
September 3, 2009: Energy Department Forced to Release Photos of MOX Transport Trucks, https://www.foe.org/photos-nuke-transport-trucks-released
2. Friends of the Earth has filed Freedom of Information Act
requests concerning examination of the MOX test rods at Oak Ridge
National Lab and also about the interest of the Tennessee Valley
Authority in MOX use. However, DOE has staunchly refused to respond to
the requests, contrary to openness directives by DOE Secretary Chu and
Attorney General Holder.
Friends of the Earth fights for a more healthy and just world. Together we speak truth to power and expose those who endanger the health of people and the planet for corporate profit. We organize to build long-term political power and campaign to change the rules of our economic and political systems that create injustice and destroy nature.
(202) 783-7400"Donald Trump and Republicans have left children and their families poorer and worse off in ways that will be felt for generations."
A report released Tuesday by Democrats on the Senate Finance Committee details how US President Donald Trump and Republicans in Congress are waging a multifront war on children by targeting healthcare programs, education, and nutrition assistance as part of their scorched-earth assault on the nation's safety net and redistribution of wealth to the very top.
"In just months, the Trump administration has gutted access to healthcare for millions of children, slashed funding for school meals and nutrition assistance, fired thousands of workers dedicated to advancing child welfare and protecting children, and unleashed policies that traumatize and harm immigrant families and LGBTQ+ youth," reads the report. "These actions are not isolated—they reflect a coordinated agenda that will leave a generation of children sicker, hungrier, and less safe."
As part of the sprawling budget reconciliation package that Trump signed into law over the summer, Republicans enacted the largest-ever cuts to Medicaid and the Supplemental Nutrition Assistance Program (SNAP), slashing more than $1 trillion combined from the two programs.
Roughly half of all kids in the US are covered by either Medicaid or the Children's Health Insurance Program, and around 40% of SNAP beneficiaries are children, meaning cuts to those programs will have far-reaching impacts on the nation's youth in the coming years.
"By making the largest cuts to healthcare and food assistance in the nation’s history, Donald Trump and Republicans have left children and their families poorer and worse off in ways that will be felt for generations," Sen. Ron Wyden (D-Ore.), the top Democrat on the Senate Finance Committee, said in a statement on Tuesday.
"By dismantling the very systems that safeguard children’s health and future, Trump and Republicans are condemning a generation to poorer health, deeper poverty, and diminished opportunity."
In addition to denouncing cuts to Medicaid and SNAP, the new report outlines how the Trump administration is imperiling mental health programs by canceling grants and other funding, harming children's education by throttling Head Start funds, and inflicting deadly cuts to programs that aid kids overseas—all while delivering massive tax cuts to the richest Americans and largest corporations.
"Trump’s cuts to healthcare access, food assistance, and education have stripped millions of kids of the care, nutrition, and protection they need to thrive," the report states. "By dismantling the very systems that safeguard children’s health and future, Trump and Republicans are condemning a generation to poorer health, deeper poverty, and diminished opportunity."
"Unless stopped," the report concludes, "Trump’s war on kids will leave lasting scars on millions of children and weaken the nation for decades to come."
"He’s not thinking about the democratization of Venezuela, let alone the narco-trafficking," said the Latin American leader. "In general, all of the wars of this century had to do with oil."
Colombian President Gustavo Petro said Tuesday that US President Donald Trump's central focus with his attacks and threats against Venezuela is the desire for the nation's vast oil reserves and little if anything to do with stopping illegal drug trafficking or improving the nation's democratic prospects under President Nicolas Maduro.
In an face-to-face interview with CNN's Isa Soeres, which the correspondent described as "fiery" at times, Petro explained that Venezuela's oil reserves, among the largest in the world, is "at the heart of the matter" when it comes to Trump's repeated extrajudicial killings in waters of the nation's coast this year and a broader military buildup that includes deployment of the USS Gerald R. Ford aircraft carrier group and mobilization of US Southern Command.
"What lies behind this," said Petro, "is the same thing behind the war in Ukraine... petroleum," noting the size and quality of Venezuela's reserves. "In general, all of the wars of this century had to do with oil."
If Trump were to get the upper hand, Petro suggested, the United States would get Venezuela's oil "almost for free," predicting that—"based on the evidence so far"—that the US will go to war over the resources.
Trump, said Petro, "is not thinking about the democratization of Venezuela, let alone the narco-trafficking," adding that Venezuela is not considered a major drug producer or transit point for most narcotics headed to the United States.
"You only have to look at the numbers," said Petro. "Only about 4 percent of Colombia's cocaine production... goes through Venezuela—a small margin—while most of it goes out through the Pacific Ocean."
As CNN notes, "Petro has been at odds with Trump since he returned to the White House. In the past year, the Colombian leader has harshly criticized the Trump administration’s immigration policies, its support for Israel and its military activity around Latin America."
In September, the US State Department under Trump had Petro's visa revoked following critical comments he made during the UN General Assembly in New York.
This week, the US designated a new group, the Cartel do Los Soles, as a terrorist organization, naming Maduro its de facto leader, a claim that experts say there is no evidence to support.
Asked by CNN if he assesses Maduro as a gang leader, dictator, or narcotrafficker, Petro said investigations in Colombia have never shown Maduro to be connected to the black market drug trade and that his country's data doesn't even show the existence of the alleged cartel designated this week by the Trump administration.
"The problem of Maduro," said Petro, "is lack of democracy and dialogue."
"Medicare drug price negotiation is about to deliver tangible lower costs to seniors in Medicare, unlike Trump’s ceremonial events with Big Pharma CEOs in the Oval Office," said one Democratic senator.
The Trump administration on Tuesday announced newly negotiated prices for more than a dozen prescription drugs covered by Medicare, an achievement made possible by a Biden-era law that has faced relentless attacks from the pharmaceutical industry, GOP lawmakers, and the Republican president.
The announcement marks the end of the second round of Medicare drug price negotiations required under the Inflation Reduction Act (IRA), a measure passed in 2022 without the support of a single Republican in Congress. Last year, House GOP leaders said the law was "disastrous" and decried what they called "the mandate from bureaucrats to artificially set prescription drug prices."
The new list contains 15 drugs, including the diabetes and weight loss medication Ozempic, the breast cancer drug Ibrance, and the prostate cancer drug Xtandi. The Centers for Medicare & Medicaid Services (CMS) estimated that if the new prices—which take effect in 2027—had been in effect last year, Medicare would have saved $12 billion.
President Donald Trump campaigned on rolling back the IRA, which for the first time allowed Medicare to negotiate drug prices directly with pharmaceutical companies. Since taking office, Trump has taken steps to weaken the law, including by signing a measure that will exempt certain high-priced drugs from Medicare negotiations—a multibillion-dollar handout to Big Pharma.
But in statements on Tuesday, Trump-appointed officials hailed the newly negotiated prices. Robert F. Kennedy Jr., secretary of the Health and Human Services Department, said the negotiation results stemmed from a Trump directive to "stop at nothing to lower healthcare costs for the American people."
CMS Administrator Mehmet Oz declared that the second round of negotiations was more successful than the first, which was held under the Biden administration. Experts said that claim is specious at best.
Democratic lawmakers were quick to highlight Republican opposition to the IRA, and continued attacks on the law, in response to the newly negotiated prices.
"Democrats took on Big Pharma by giving Medicare the power to negotiate on behalf of the tens of millions of seniors that want lower drug prices while every Republican voted against it,” said Sen. Ron Wyden (D-Ore.), the top Democrat on the Senate Finance Committee. “Today’s announcement is a result of that effort by Democrats to lower health costs for older Americans."
"Medicare drug price negotiation is about to deliver tangible lower costs to seniors in Medicare, unlike Trump’s ceremonial events with Big Pharma CEOs in the Oval Office," Wyden added. "Republicans neutered future Medicare drug price negotiations by adding delays and exemptions to some of the most expensive drugs, especially cancer drugs like Keytruda."
Tuesday's announcement came less than a week after the pharmaceutical industry suffered its 16th defeat in court as it continues its legal campaign against the Medicare price negotiations. The industry is also lobbying aggressively in support of legislation that would further weaken the IRA price-negotiation provisions.
"Drug corporations already secured a $9 billion giveaway from President Trump and congressional Republicans paid for by taxpayers and cancer patients through the Big Ugly Bill, and they are trying to go even further to delay and exempt price negotiations for more blockbuster drugs," said Steve Knievel, access to medicines advocate at Public Citizen.
"Policymakers must reject these efforts to undermine Medicare drug price negotiations," Knievel added. "Instead they should build on the program’s success by providing everyone access to negotiated prices, negotiating lower prices for more drugs sooner, and ensuring drug corporations can no longer rip us off by charging the highest prices in the world for medications."